Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas

Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas

Play all audios:

Loading...

ABSTRACT Altered expression of the retinoblastoma (RB) tumour-suppressor gene product (pRB) has been detected in sporadic bone and soft-tissue sarcomas. Earlier studies, analysing small cohorts of sarcoma patients, have suggested that these alterations are more commonly associated with high-grade tumours, metastatic lesions and poorer survival. This study was designed to re-examine the prevalence and clinical significance of altered pRB expression in a large and selected group of soft-tissue sarcomas from 174 adult patients. Representative tissue sections from these sarcomas were analysed by immunohistochemistry using a well-characterised anti-pRB monoclonal antibody. Tumours were considered to have a positive pRB phenotype only when pure nuclear staining was demonstrated, and cases were segregated into one of three groups. Group 1 (n = 36) were patients whose tumours have minimal or undetectable pRB nuclear staining (< 20% of tumour cells) and were considered pRB negative. Patients with tumours staining in a heterogeneous pattern (20-79% of tumour cells) were classified as group 2 (n = 99). The staining of group 3 (n = 39) was strongly positive with a homogeneous pRB nuclear immunoreactivity (80-100% of tumour cells). pRB alterations were frequently observed in both low- and high-grade lesions. Altered pRB expression did not correlate with known predictors of survival and was not itself an independent predictor of outcome in the long-term follow-up. These findings support earlier observations that alterations of pRB expression are common events in soft-tissue sarcomas; nevertheless, long-term follow-up results indicate that altered patterns of pRB expression do not influence clinical outcome of patients affected with soft-tissue sarcomas. It is postulated that RB alterations are primary events in human sarcomas and may be involved in tumorigenesis or early phases of tumour progression in these neoplasias. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 24 print issues and online access $259.00 per year only $10.79 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS CLINICAL SEQUENCING OF SOFT TISSUE AND BONE SARCOMAS DELINEATES DIVERSE GENOMIC LANDSCAPES AND POTENTIAL THERAPEUTIC TARGETS Article Open access 15 June 2022 CLINICAL GENOMIC PROFILING IN THE MANAGEMENT OF PATIENTS WITH SOFT TISSUE AND BONE SARCOMA Article Open access 15 June 2022 PREDICTIVE AND PROGNOSTIC TRANSCRIPTOMIC BIOMARKERS IN SOFT TISSUE SARCOMAS Article Open access 05 March 2021 AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA MS Karpeh Authors * MS Karpeh View author publications You can also search for this author inPubMed Google Scholar * MF Brennan View author publications You can also search for this author inPubMed Google Scholar * WG Cance View author publications You can also search for this author inPubMed Google Scholar * JM Woodruff View author publications You can also search for this author inPubMed Google Scholar * D Pollack View author publications You can also search for this author inPubMed Google Scholar * ES Casper View author publications You can also search for this author inPubMed Google Scholar * ME Dudas View author publications You can also search for this author inPubMed Google Scholar * E Latres View author publications You can also search for this author inPubMed Google Scholar * M Drobnjak View author publications You can also search for this author inPubMed Google Scholar * C Cordon-Cardo View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Karpeh, M., Brennan, M., Cance, W. _et al._ Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. _Br J Cancer_ 72, 986–991 (1995). https://doi.org/10.1038/bjc.1995.447 Download citation * Issue Date: 01 October 1995 * DOI: https://doi.org/10.1038/bjc.1995.447 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

ABSTRACT Altered expression of the retinoblastoma (RB) tumour-suppressor gene product (pRB) has been detected in sporadic bone and soft-tissue sarcomas. Earlier studies, analysing small


cohorts of sarcoma patients, have suggested that these alterations are more commonly associated with high-grade tumours, metastatic lesions and poorer survival. This study was designed to


re-examine the prevalence and clinical significance of altered pRB expression in a large and selected group of soft-tissue sarcomas from 174 adult patients. Representative tissue sections


from these sarcomas were analysed by immunohistochemistry using a well-characterised anti-pRB monoclonal antibody. Tumours were considered to have a positive pRB phenotype only when pure


nuclear staining was demonstrated, and cases were segregated into one of three groups. Group 1 (n = 36) were patients whose tumours have minimal or undetectable pRB nuclear staining (<


20% of tumour cells) and were considered pRB negative. Patients with tumours staining in a heterogeneous pattern (20-79% of tumour cells) were classified as group 2 (n = 99). The staining of


group 3 (n = 39) was strongly positive with a homogeneous pRB nuclear immunoreactivity (80-100% of tumour cells). pRB alterations were frequently observed in both low- and high-grade


lesions. Altered pRB expression did not correlate with known predictors of survival and was not itself an independent predictor of outcome in the long-term follow-up. These findings support


earlier observations that alterations of pRB expression are common events in soft-tissue sarcomas; nevertheless, long-term follow-up results indicate that altered patterns of pRB expression


do not influence clinical outcome of patients affected with soft-tissue sarcomas. It is postulated that RB alterations are primary events in human sarcomas and may be involved in


tumorigenesis or early phases of tumour progression in these neoplasias. Access through your institution Buy or subscribe This is a preview of subscription content, access via your


institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 24 print issues and online access $259.00 per year only $10.79 per issue Learn more Buy this


article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in


* Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS CLINICAL SEQUENCING OF SOFT TISSUE AND BONE SARCOMAS DELINEATES


DIVERSE GENOMIC LANDSCAPES AND POTENTIAL THERAPEUTIC TARGETS Article Open access 15 June 2022 CLINICAL GENOMIC PROFILING IN THE MANAGEMENT OF PATIENTS WITH SOFT TISSUE AND BONE SARCOMA


Article Open access 15 June 2022 PREDICTIVE AND PROGNOSTIC TRANSCRIPTOMIC BIOMARKERS IN SOFT TISSUE SARCOMAS Article Open access 05 March 2021 AUTHOR INFORMATION AUTHORS AND AFFILIATIONS *


Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA MS Karpeh Authors * MS Karpeh View author publications You can also search for this author inPubMed Google


Scholar * MF Brennan View author publications You can also search for this author inPubMed Google Scholar * WG Cance View author publications You can also search for this author inPubMed 


Google Scholar * JM Woodruff View author publications You can also search for this author inPubMed Google Scholar * D Pollack View author publications You can also search for this author


inPubMed Google Scholar * ES Casper View author publications You can also search for this author inPubMed Google Scholar * ME Dudas View author publications You can also search for this


author inPubMed Google Scholar * E Latres View author publications You can also search for this author inPubMed Google Scholar * M Drobnjak View author publications You can also search for


this author inPubMed Google Scholar * C Cordon-Cardo View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions


ABOUT THIS ARTICLE CITE THIS ARTICLE Karpeh, M., Brennan, M., Cance, W. _et al._ Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. _Br J Cancer_ 72,


986–991 (1995). https://doi.org/10.1038/bjc.1995.447 Download citation * Issue Date: 01 October 1995 * DOI: https://doi.org/10.1038/bjc.1995.447 SHARE THIS ARTICLE Anyone you share the


following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer


Nature SharedIt content-sharing initiative